(S (NP-SBJ-1 (NP (ADJP (RB Minimally) (VBN modified) (JJ low) (NN density) (JJ lipoprotein-induced)) (JJ inflammatory) (NNS responses)) (PP (IN in) (NP (JJ endothelial) (NNS cells)))) (VP (VBP are) (VP (VBN mediated) (NP (-NONE- *-1)) (PP (IN by) (NP-LGS (JJ cyclic) (NN adenosine) (NN monophosphate))))) (. .))
(S (NP-SBJ (PRP We)) (VP (VBP have) (ADVP-TMP (RB previously)) (VP (VBN shown) (SBAR (IN that) (S (NP-SBJ-3 (NP (ADJP (RB minimally) (VBN oxidized)) (NN LDL)) (PRN (-LRB- -LRB-) (NP (NN MM-LDL)) (-RRB- -RRB-))) (VP (VBD activated) (NP-2 (JJ endothelial) (NNS cells)) (S (NP-SBJ (-NONE- *-2)) (VP (TO to) (VP (VB increase) (NP (NP (PRP$ their) (NN interaction)) (PP (IN with) (NP-COOD (NP (NNS monocytes)) (CONJP (CC but) (RB not)) (NP (NNS neutrophils)))))))) (, ,) (S (NP-SBJ (-NONE- *-3)) (VP (VBG inducing) (NP (NP (NP-COOD (NP (NN monocyte)) (CONJP (CC but) (RB not)) (NP (NN neutrophil))) (NP-COOD (NP (NN binding)) (CC and) (NP (NN synthesis)))) (PP (IN of) (NP-COOD (NP (NN monocyte) (JJ chemotactic) (NN protein-1)) (CC and) (NP (NP (NN monocyte) (JJ colony-stimulating) (NN factor)) (PRN (-LRB- -LRB-) (NP (NN M-CSF)) (-RRB- -RRB-))))))))))))) (. .))
(S (PP (IN In) (NP (DT the) (JJ present) (NNS studies))) (NP-SBJ (PRP we)) (VP (VBP have) (VP (VBN examined) (NP (NP (DT the) (NN signaling) (NNS pathways)) (SBAR (WHPP-4 (IN by) (WHNP (WDT which))) (S (NP-SBJ-5 (DT this) (JJ monocyte-specific) (NN response)) (VP (VBZ is) (VP (VBN induced) (NP (-NONE- *-5)) (PP (-NONE- *T*-4))))))))) (. .))
(S (NP-SBJ-6 (NP (CC Both) (NP (NP (NN induction)) (PP (IN of) (NP (NN monocyte) (NN binding)))) (CC and) (NP (NP (NN mRNA) (NNS levels)) (PP (IN for) (NP (NN M-CSF))))) (PP (IN by) (NP (NN MM-LDL)))) (VP (VBD were) (RB not) (VP (VBN inhibited) (NP (-NONE- *-6)) (PP (IN in) (NP (ADJP (NN protein) (NN kinase) (JJ C-depleted)) (JJ endothelial) (NNS cells))))) (. .))
(S (NP-SBJ (NP (DT A) (NN number)) (PP (IN of) (NP (PRP$ our) (NNS studies)))) (VP (VBP indicate) (SBAR (IN that) (S (NP-SBJ (NN cAMP)) (VP (VBZ is) (NP-PRD (NP (DT the) (JJ second) (NN messenger)) (PP (IN for) (NP (NP (DT the) (NNS effects)) (PP (IN of) (NP (NN MM-LDL))) (VP (VBN cited) (NP (-NONE- *)) (ADVP (RB above)))))))))) (. .))
(S (NP-SBJ (NP (NN Incubation)) (PP (IN of) (NP (JJ endothelial) (NNS cells))) (PP (IN with) (NP (NN MM-LDL) (VBD caused)))) (VP (DT a) (NP (NP (CD 173) (ADJP (NN %)) (NN increase)) (PP (IN in) (NP (JJ intracellular) (NN cAMP) (NNS levels))))) (. .))
(S (NP-SBJ (NP (NNS Agents)) (SBAR (WHNP-8 (WDT which)) (S (NP-SBJ (-NONE- *T*-8)) (VP (VBD increased) (NP (NN cAMP) (NNS levels))))) (, ,) (PP (VBG including) (NP-COOD (NP (NN cholera) (NN toxin)) (, ,) (NP (NN pertussis) (NN toxin)) (, ,) (NP (NN dibutyryl) (NN cAMP)) (, ,) (CC and) (NP (NN isoproterenol))))) (VP (VBD mimicked) (NP (NP (DT the) (NNS actions)) (PP (IN of) (NP (NN MM-LDL))))) (. .))
(S (NP-SBJ-9 (NP (NNS Agents)) (SBAR (WHNP-10 (WDT which)) (S (NP-SBJ (-NONE- *T*-10)) (VP (VBD elevated) (NP (NN cAMP)))))) (VP (VBD were) (ADVP (RB also)) (VP (VBN shown) (S (NP-SBJ (-NONE- *-9)) (VP (TO to) (VP (VB activate) (NP (NN NF) (NN kappa) (NN B)) (, ,) (S (NP-SBJ (-NONE- *)) (VP (VBG suggesting) (NP (NP (DT a) (NN role)) (PP (IN for) (NP (DT this) (NN transcription) (NN factor))) (PP (IN in) (NP (NP (NN activation)) (PP (IN of) (NP (JJ monocyte-endothelial) (NNS interactions))))))))))))) (. .))
(S (SBAR (IN Although) (S (NP-SBJ-12 (NP (NP (JJ endothelial) (NN leukocyte) (NN adhesion) (NN molecule)) (PRN (-LRB- -LRB-) (NP (NN ELAM)) (-RRB- -RRB-))) (NN mRNA) (NN synthesis)) (VP (MD can) (VP (VB be) (VP (VBN regulated) (NP (-NONE- *-12)) (PP (IN by) (NP-LGS (NN NF) (NN kappa) (NN B)))))))) (, ,) (S-COOD (S (NP-SBJ-14 (NN ELAM)) (VP (VBD was) (RB not) (VP (VBN expressed) (NP (-NONE- *-14))))) (CC and) (S (NP-SBJ-13 (NN ELAM) (NN mRNA)) (VP (VBD was) (ADVP (RB only) (RB slightly)) (VP (JJ elevated) (NP (-NONE- *-13)) (PP (IN in) (NN response) (TO to) (NP (NN MM-LDL))))))) (. .))
(S (NP-SBJ (PRP We)) (VP (VBP present) (NP (NN evidence) (SBAR (IN that) (S (NP-SBJ-15 (NP (NN induction)) (PP (IN of) (NP (NN neutrophil) (NN binding))) (PP (IN by) (NP (NN LPS)))) (VP (VBZ is) (ADVP (RB actually)) (VP (VBN suppressed) (NP (-NONE- *-15)) (PP (IN by) (NP-LGS (NP (NNS agents)) (SBAR (WHNP-16 (WDT that)) (S (NP-SBJ (-NONE- *T*-16)) (VP (VBD elevated) (NP (NN cAMP) (NNS levels))))))))))))) (. .))
